Cell and gene therapy: sustaining growth and maximizing opportunities
Cell and gene therapies are transforming the way diseases are treated. As research progresses it is hoped that cell and gene therapies will offer innovation for the future.
In this webinar, you will hear from CBO/CDO of Adthera Bio, Stuart Curbishley, Chief Executive Officer of Cell & Gene Therapy Catapult, Matthew Durdy, Scientific Solutions Consultant of Benchling, Brian Fan, and Founder and CEO of Dark Horse Consulting, Anthony Davies.
The event will cover aspects affecting growth of the CGT market, including how manufacturing technologies are enabling drug development, what these therapies mean for the healthcare market, and the opportunities for developers.
The opportunities cell and gene therapies offer drug discovery and development
How to sustain and maximize market growth
The challenges facing cell and gene therapies
Where are the opportunities for innovation? (autologous therapies/solid tumors/ indications outside of oncology?)
